J.C. Penney (NYSE: JCP ) has attracted another high-profile investor to its roster of major shareholders. Billionaire George Soros has disclosed ownership of a sizable block of shares in the company, according to a filing his Soros Fund Management submitted to the Securities and Exchange Commission.
According to the filing, Soros now holds nearly 17.4 million shares in the struggling retailer, or 7.9% of the company.
The move is a typically contrarian play for the veteran financier. J.C. Penney stock has lost more than half its value over the past year and is down by 23% so far in 2013.
Top 10 Consumer Service Companies To Invest In Right Now: Chelsea Therapeutics International Ltd.(CHTP)
Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for the treatment of various human diseases. It is involved in developing Droxidopa, a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with primary autonomic failure and falls related to NOH in Parkinson?s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue syndrome, and freezing of gait in PD and down syndrome. The company intends to market its Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn?s disease, ankylosing spondylitis, uveitis, psoriatic arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The company?s molecule products include a portfolio of metabolically inert antifolate molecules consisting of CH-1504 and CH-4051, which are orally available molecules with anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.
Advisors' Opinion:- [By MONEYMORNING]
Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) is a 10-year-old development-stage biopharmaceutical company headquartered in Charlotte, N.C. Shares got our attention mid-month when the stock soared 160% on heavy volume after a panel of federal experts recommended approval of its most advanced candidate, Northera. A blood pressure treatment designed to prevent dizziness and fainting in Parkinson's disease patients, the advisory group concluded the drug is effective enough to warrant regulatory approval. The outside panel's endorsement came with the condition the drug only be approved for short-term use in a defined group of patients.
Top 10 Managed Healthcare Stocks To Watch Right Now: Lean Hogs (HE)
Hawaiian Electric Industries, Inc., through its subsidiaries, primarily engages in electric utility and banking businesses primarily in Hawaii. The company is involved in the production, purchase, transmission, distribution, and sale of electricity from renewable energy sources, such as wind, solar, photovoltaic, geothermal, wave, hydroelectric, sugarcane waste, municipal waste, and other biofuels, as well as from fuel oil. It distributes and sells electricity on the islands of Oahu, Hawaii, Maui, Lanai, and Molokai; and serves suburban communities, resorts, the United States armed forces installations, and agricultural operations. As of December 31, 2011, the company had net generating and firm purchased capability of 2,326.9 megawatts. It also engages in providing banking and other financial services, such as accepting savings accounts, checking accounts, money market accounts, and certificates of deposit; and providing loans comprising residential and commercial real es tate, residential mortgage, construction and development, multifamily residential and commercial real estate, consumer, and commercial loans to consumers and business. The company operated 57 branches and 119 automated teller machines. Hawaiian Electric Industries, Inc. was founded in 1891 and is based in Honolulu, Hawaii.
Advisors' Opinion:- [By Geoff Gannon]
路 Within 5 or 6 hours��(he) found 20 stocks selling at 2 or 3 (times) earnings with strong balance sheets.
路 Korea rebuilt itself in a big way post 1998. Companies overbuilt their balance sheets.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Utilities stocks gained Friday, with Korea Electric Power (NYSE: KEP) leading advancers. Meanwhile, gainers in the sector included Huaneng Power International (NYSE: HNP), with shares up 1.8 percent, and Hawaiian Electric Industries (NYSE: HE), with shares up 1.4 percent. - [By Jake L'Ecuyer]
Utilities shares dropped by 0.31 percent in the US market today. Among the sector stocks, Hawaiian Electric Industries (NYSE: HE) was down more than 2.9 percent, while Edison International (NYSE: EIX) tumbled around 1.4 percent.
Top 10 Managed Healthcare Stocks To Watch Right Now: Triangle Petroleum Corporation (TPLM)
Triangle Petroleum Corporation engages in the acquisition, exploration, development, and production of unconventional shale oil and natural gas resources in the Bakken Shale and Three Forks formations in the Williston Basin of North Dakota and Montana. As of January 31, 2013, the company held leasehold interests in approximately 86,000 net acres in McKenzie and Williams Counties of North Dakota, and Roosevelt and Sheridan Counties of Montana. It also holds an 87% working interest in approximately 412,924 net acres of oil and natural gas leases in the Windsor Sub-Basin of the Maritimes Basin located in Nova Scotia, Canada. In addition, the company offers hydraulic pressure pumping and complementary well completion services to oil and natural gas exploration and production companies in the Williston Basin of North Dakota and Montana. The company was formerly known as Peloton Resources Inc. and changed its name to Triangle Petroleum Corporation in May 2005. Triangle Petroleum Corporation was incorporated in 2003 and is headquartered in Denver, Colorado.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of Triangle Petroleum� (NYSEMKT: TPLM ) �jumped 10% today after the company released earnings.
So what: Revenue rose 17% in the quarter to $34.3 million, above the $31.5 million estimate. On the bottom line, the company went from a $3 million loss a year ago to a $5.2 million profit, or $0.10 per share, double what Wall Street estimated. �
- [By Tyler Crowe]
Despite the fact that Kodiak Oil & Gas (NYSE: KOG ) has decided to be acquired by Whiting Petroleum (NYSE: WLL ) for slightly less than market value for similar deals recently, Wall Street seems to love the transaction. Both Kodiak and Whiting have seen shares climb by 10.1% and 10.4%, respectively, following the announcement, which suggests there might have been something bigger to the deal. Let's take a look at what has changed recently for Kodiak and how that could impact other smaller players in the Bakken such as Oasis Petroleum (NYSE: OAS ) and Triangle Petroleum (NYSEMKT: TPLM ) .
- [By John Udovich]
Small cap Triangle Petroleum Corporation (NYSEMKT: TPLM), just like its peers Emerald Oil Inc (NYSEMKT: EOX) and Kodiak Oil & Gas Corp (NYSE: KOG), is focused on the Williston Basin�� Bakken and Three Forks formations and the company is scheduled to release second quarter fiscal year 2014 financial results after the close of trading�next Monday.�And the last time earnings were reported, shares jumped around 10% plus management gave some rosy commentary for investors. With that in mind, should investors in Triangle Petroleum Corporation be ready for another earnings report that excites the bulls?
- [By Bret Jensen]
Triangle Petroleum (TPLM) came within pennies of doubling since I profiled it at $5.40 a share back in June on Friday. This was twenty months before my prediction that the fast growing concern could achieve those levels. Triangle shows there can quite a bit a value still left among the smaller Bakken players. I view these small E&P firms almost like biotechs and use the same form of "shotgun investing" I do with that sector. Here are two small Bakken producers which could award aggressive growth investors in the future.
Top 10 Managed Healthcare Stocks To Watch Right Now: Newpark Resources Inc (NR)
Newpark Resources, Inc., incorporated on June 3, 1988, is a diversified oil and gas supplier providing products and services primarily to the oil and gases exploration (E&P) industry. The Company operates in three segments: fluids systems and engineering, mats and integrated services, and environmental services. The Company's Fluids Systems and Engineering segment provides customized drilling fluids solutions to E&P customers globally, operating through four geographic regions: North America, Europe, the Middle East and Africa (EMEA), Latin America, and Asia Pacific. The Company's Mats and Integrated Services segment provides composite mat rentals, well site construction and related site services to oil and gas customers at well, production, transportation and refinery locations in the United States. The Company's Environmental Services segment processes and disposes of waste generated by E&P and industrial activity, primarily along the United States Gulf Coast. On December 31, 2012, it acquired operations of Alliance Drilling Fluids, LLC
Fluids Systems and Engineering
The Company's Fluids Systems and Engineering business offers customized solutions, including technical drilling projects involving complex subsurface conditions, such as horizontal, directional, geologically deep or deep water drilling. These projects require increased monitoring and critical engineering support of the fluids system during the drilling process. The Company provides drilling fluids products and technical services to markets in North America, EMEA, Latin America, and the Asia Pacific region. The Company also provides completion services and equipment rental to customers in Oklahoma and Texas. The Company has industrial mineral grinding operations for barite. The Company grinds barite and other industrial minerals at facilities in Houston and Corpus Christi, Texas, New Iberia, Louisiana and Dyersburg, Tennessee. The Company uses the resulting products in its drilling fluids business, and also sell! s them to third party users, including other drilling fluids companies. The Company also sells a variety of other minerals, principally to third party industrial (non oil and gas) markets, from its main plant in Houston, Texas and from the plant in Dyersburg, Tennessee.
Mats and Integrated Services
The Company provides mat rentals, location construction and related well sites services to E&P customers in the Northeast United States, onshore United States Gulf Coast, and Rocky Mountain regions, and mat rentals to the petrochemical industry in the United States and the utility industry in the United Kingdom. These mats provide environmental protection and ensure all-weather access to sites with unstable soil conditions. The Company manufactures its DuraBase Advanced Composite Mats for sales, as well as for uses in its domestic and international rental operations. The Company's marketing efforts for this product remain focused in principal oil and gas industry markets which include the Asia Pacific, Latin America, EMEA, as well as markets outside the E&P sector in the United States and Europe.
Environmental Services
The Company processes and disposes of waste generated by its oil and gas customers. Primary revenue sources include onshore and offshore Gulf of Mexico drilling waste management, as well as reclamation services. Additionally, the Company provides disposal services in the West Texas market. The Company operates six receiving and transfers facilities located along the United States Gulf Coast. E&P waste is collected at the transfer facilities from drilling and production operations located offshore, onshore and within inland waters. Waste is accumulated at the transfer facilities and moved by barge through the Gulf Intracoastal Waterway to the Company's processing and transfer facility at Port Arthur, Texas, and, if not recycled, is trucked to injection disposal facilities. Any remaining material is injected, after further processing, into envir! onmentall! y secure geologic formations. Under permits from Texas state regulatory agencies, the Company operates waste disposal facilities in Jefferson County, Texas (Fannett and Big Hill). The Fannett site is the Company's primary facility for disposing of E&P waste. Utilizing this same technology, the Company also receives and disposes of non-hazardous industrial waste at the Big Hill facility, principally from generators in the United States Gulf Coast market, including refiners, manufacturers, service companies and industrial municipalities that produce waste. These non-hazardous waste streams are injected into a separate well utilizing the same low-pressure injection technology. The Company also disposes of non-hazardous industrial waste.
The Company competes with Schlumberger, Halliburton and Baker Hughes.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of energy service provider Newpark Resources (NYSE: NR ) jumped 17% today after the company released earnings.
So what: Revenue was up 7.7%, to $283 million in the first quarter, and net income jumped 11.1%, to $17.4 million, or $0.18 per share. Analysts only expected $278 million in revenue, and earnings of $0.17 per share, and the slight beat was enough to send shares higher. It didn't hurt that the report was accompanied by a $50 million share repurchase plan, which indicates that management is bullish on the company's long-term future.�
Top 10 Managed Healthcare Stocks To Watch Right Now: XenoPort Inc.(XNPT)
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing internally discovered product candidates that utilize the body?s natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. The company licenses its lead product candidate Gabapentin Enacarbil, a transported prodrug of gabapentin, to Astellas Pharma Inc. in Japan and five Asian countries, as well as to Glaxo Group Limited in the United States. Astellas Pharma Inc. filed new drug application for the approval of Gabapentin Enacarbil as a treatment for restless legs syndrome in Japan. The company also develops Arbaclofen Placarbil, which completed a Phase II clinical trial for the treatment of spasticity in patients with spinal cord injury. In addition, it develops Arbaclofen Placarbil for the treatment of gastroesophageal reflux disease. Further, the company develops XP21279, which is in Phase II clinical trial for the treatment of Parkinson?s disease; and XP2382 9, a novel prodrug of methylhydrogenfumarate that is in preclinical stage. It has strategic alliances with Astellas Pharma, Inc. and Glaxo Group Limited. The company was founded in 1999 and is based in Santa Clara, California.
Advisors' Opinion:- [By Max Macaluso, Ph.D.]
Treatments for RLS
While a better understanding of RLS and its long-term impact on health are needed, there are FDA-approved drugs available to treat the symptoms of this disorder. GlaxoSmithKline (NYSE: GSK ) brought a RLS drug, Requip, to market eight years ago, and the drug was also approved for Parkinson's disease. Total sales of the medication have been falling in recent years due to generic competition and reached only 164 million pounds ($257.5 million) in 2012. Until recently, GSK also had a second RLS drug called Horizant in collaboration with biotech company XenoPort (NASDAQ: XNPT ) . GSK recently handed the rights to the drug back to XenoPort after sales failed to meet its expectations, and the biotech is now commercializing the drug alone.
Top 10 Managed Healthcare Stocks To Watch Right Now: Financial Engines Inc.(FNGN)
Financial Engines, Inc. and its subsidiaries provide independent, technology-enabled portfolio management services, investment advice, and retirement income services to participants in employer-sponsored defined contribution plans. The company helps investors plan for retirement by offering personalized plans for saving and investing, as well as by providing assessments of retirement income needs and readiness. Its services include Professional Management, a discretionary managed account service designed for plan participants who want personalized and professional portfolio management services, investment advice, and retirement income services from an independent investment advisor; Online Advice, an Internet-based non-discretionary service that offers personalized advice to plan participants who manage their portfolios directly; and Retirement Evaluation, a retirement readiness assessment provided to plan participants upon plan rollout. The company delivers its services t o plan sponsors and plan participants primarily through connections to eight retirement plan providers in the United States. Financial Engines, Inc. was founded in 1996 and is headquartered in Palo Alto, California.
Advisors' Opinion:- [By GURUFOCUS]
Our biggest contributor this quarter was Financial Engines, Inc. (FNGN), which provides personalized independent investment management and advice to employees for their retirement plans. The stock rose 26.0%. Revenues grew an impressive 29% in the first quarter, driven by additional corporate clients, more employee participation and stock market appreciation. The company recently introduced "Income Plus" an alternative to "target date" fund offerings, which is being well received and opens up potential new growth opportunities.
- [By Ben Levisohn]
The iShares Russell 2000 ETF (IWM) has dropped 5.2% so far this year, while Mueller Industries (MLI), which has plunged 55%, Medidata Solutions (MDSO), which has plummeted 44%, Financial Engines (FNGN), which has slid 42%, and Isis Pharmaceuticals (ISIS), which has tumbled 42%, are the index’s biggest losers.
Top 10 Managed Healthcare Stocks To Watch Right Now: H&Q Life Sciences Investors (HQL)
H&Q Life Sciences Investors (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in life science companies (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies) agriculture and environmental management. The Fund invests primarily in securities of public and private companies.
The Fund may invest in venture capital and other restricted securities if these securities would comprise 40% or less of net assets. The Fund may purchase and sell (or write) put or call options on any security in which it is permitted to invest. It may purchase and sell (write) options on stock indices (index options). H&Q Life Sciences Investors��investment advisor is Hambrecht & Quist Capital Management, LLC.
Advisors' Opinion:- [By Nate Pile]
This recommended fund��ambrecht & Quist Life Sciences Fund (HQL)��as also our top pick last year, and the fund rose 44% in 2013.
In addition to rising in value, the fund has a dividend policy of paying out 2% of its net asset value of each quarter.
- [By Harry Domash, Publisher, DividendDetective and Winning Investing]
Harry Domash: Yeah, in fact, H&Q Life Sciences, ticker (HQL), is actually a closed-end fund, but it invests entirely in biotech and pharmaceutical companies, and if you look around the world, the investing stocks right now—besides the social media stocks—that's really the one area that has had a lot of recent growth and we expect that to continue.
I think the closed-end fund, and we'll get into that maybe a little bit later, but closed-end funds are a good way to cover it, when you're talking about a sector like that.
Johnson & Johnson is an interesting case, because, as you know, Johnson & Johnson is a big company that invests, and that owns a lot of different companies itself in the medical field.
You know, it owns hundreds of operating companies and it's primarily in the pharmaceuticals, and medical devices, and in consumer products, but Johnson & Johnson was a mismanaged company for a while and they were really underperforming their peers.
In fact, some of their factories were closed, their pharmaceutical production factories were forcibly closed by the government because they didn't meet standards, but they were taken over by a new CEO a few years ago, two or three years ago, and now things are improving, so Johnson & Johnson is kind of coming from down and out to being a leading company again.
They've got a lot of products, cancer-type products, and things on the pipeline and it just seems like things are going very well so we have hopes that Johnson & Johnson has reported the last two quarters are the first ones that have really been decent, they really showed growth, and then we expect that to accelerate so we're pretty hot on Johnson & Johnson now.
Steve Halpern: One particularly interesting portfolio that you maintain that I haven't seen anywhere else is based on closed-end funds that pay monthly dividends&mdash
No comments:
Post a Comment